South Africa Lung Cancer Diagnostics Market to 2032

Overview

The South Africa Lung Cancer Diagnostics Market is expected to reach a 108.93 USD Billion by 2032 and is projected to grow at a CAGR of 15.70% from 2025 to 2032.

Revenue, 2024 (USD Billion)
46.31
Forecast, 2032 (USD Billion)
108.93
CAGR, 2024 - 2032
15.70%
Report Coverage
South Africa

South Africa Lung Cancer Diagnostics Market 2018-2032 USD Billion

South Africa Lung Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 46.31 USD Billion
  • Projected Market Size (2032): 108.93 USD Billion
  • CAGR (2025-2032): 15.70%

Key Findings of South Africa Lung Cancer Diagnostics Market

  • The South Africa Lung Cancer Diagnostics Market was valued at 46.31 USD Billion in 2024.
  • The South Africa Lung Cancer Diagnostics Market is likely to grow at a CAGR of 15.70% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Non-Small Cell Lung Cancer in Cancer Segment accounted for the largest share of the market with a revenue of 37.07 USD Billion
  • The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 17.28% during the forecast period from 2024 to 2032.

South Africa Lung Cancer Diagnostics Market Scope

South Africa Lung Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tender
Test
  • Others
  • Blood Test
  • Biopsy
  • Biomarkers Test
  • Imaging Test
End User
  • Others
  • Cancer Research Institutes
  • Diagnostic Imaging Centers
  • Independent Diagnostic Laboratories
  • Associated Labs
  • Hospital
Product
  • Consumables & Accessories
  • Instruments
Cancer
  • Small Cell Lung Cancer
  • Non-Small Cell Lung Cancer

South Africa Lung Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Billion
Market Value in 2024 46.31 USD Billion
Market Value in 2032 108.93 USD Billion
CAGR (2025-2032) 15.70%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,Test,End User,Product,Cancer

Regional Insights:

  • Leading Market (2024-2032): South Africa, leading in terms of revenue 46.31 USD Billion in 2024
    • Key Country: South Africa, leading in terms of revenue with value of 46.31 USD Billion in 2024.

Segments and Scope

  • South Africa Lung Cancer Diagnostics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in South Africa Lung Cancer Diagnostics Market to 2032 with a revenue of 28.66 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in South Africa Lung Cancer Diagnostics Market to 2032 with a Growth rate of 16.69 % in forecast period 2025-2032.
  • South Africa Lung Cancer Diagnostics Market to 2032, By Test
    • Imaging Test is the largest segment in South Africa Lung Cancer Diagnostics Market to 2032 with a revenue of 26.02 USD Billion in the year 2024.
    • Imaging Test is the Fastest growing segment in South Africa Lung Cancer Diagnostics Market to 2032 with a Growth rate of 16.56 % in forecast period 2025-2032.
  • South Africa Lung Cancer Diagnostics Market to 2032, By End User
    • Hospital is the largest segment in South Africa Lung Cancer Diagnostics Market to 2032 with a revenue of 16.93 USD Billion in the year 2024.
    • Hospital is the Fastest growing segment in South Africa Lung Cancer Diagnostics Market to 2032 with a Growth rate of 17.28 % in forecast period 2025-2032.
  • South Africa Lung Cancer Diagnostics Market to 2032, By Product
    • Instruments is the largest segment in South Africa Lung Cancer Diagnostics Market to 2032 with a revenue of 31.79 USD Billion in the year 2024.
    • Instruments is the Fastest growing segment in South Africa Lung Cancer Diagnostics Market to 2032 with a Growth rate of 16.44 % in forecast period 2025-2032.
  • South Africa Lung Cancer Diagnostics Market to 2032, By Cancer
    • Non-Small Cell Lung Cancer is the largest segment in South Africa Lung Cancer Diagnostics Market to 2032 with a revenue of 37.07 USD Billion in the year 2024.
    • Non-Small Cell Lung Cancer is the Fastest growing segment in South Africa Lung Cancer Diagnostics Market to 2032 with a Growth rate of 15.90 % in forecast period 2025-2032.

South Africa Lung Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Thermo Fisher Scientific Inc.
Quest Diagnostics Incorporated
Bio-Rad Laboratories, Inc.
Abbott
Guardant Health
South Africa Lung Cancer Diagnostics Market Company Share Analysis

South Africa Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

South Africa Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

South Africa Lung Cancer Diagnostics Market Company Profiling

South Africa Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The South Africa Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,Test,End User,Product,Cancer.
South Africa Lung Cancer Diagnostics Market was valued at USD 46.31(Revenue in USD Billion) in 2021.
South Africa Lung Cancer Diagnostics Market is projected to grow at a CAGR of 15.70% during the forecast period of 2024 to 2032.
The Non-Small Cell Lung Cancer segment is expected to dominate the South Africa Lung Cancer Diagnostics Market, holding a largest market share of 37.07 USD Billion in 2024

South Africa Lung Cancer Diagnostics Market Scope

South Africa Lung Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tender
Test
  • Others
  • Blood Test
  • Biopsy
  • Biomarkers Test
  • Imaging Test
End User
  • Others
  • Cancer Research Institutes
  • Diagnostic Imaging Centers
  • Independent Diagnostic Laboratories
  • Associated Labs
  • Hospital
Product
  • Consumables & Accessories
  • Instruments
Cancer
  • Small Cell Lung Cancer
  • Non-Small Cell Lung Cancer
Frequently Asked Questions
The South Africa Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,Test,End User,Product,Cancer.
South Africa Lung Cancer Diagnostics Market was valued at USD 46.31(Revenue in USD Billion) in 2021.
South Africa Lung Cancer Diagnostics Market is projected to grow at a CAGR of 15.70% during the forecast period of 2024 to 2032.
The estimated market value of the South Africa Lung Cancer Diagnostics Market for final year is USD 108.93 (USD Billion).

South Africa Lung Cancer Diagnostics Market Company Profiling

South Africa Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The South Africa Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,Test,End User,Product,Cancer.
South Africa Lung Cancer Diagnostics Market was valued at USD 46.31(Revenue in USD Billion) in 2021.
South Africa Lung Cancer Diagnostics Market is projected to grow at a CAGR of 15.70% during the forecast period of 2024 to 2032.
The estimated market value of the South Africa Lung Cancer Diagnostics Market for final year is USD 108.93 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.